These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11413513)

  • 41. Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands.
    Kelder W; Inberg B; Schaapveld M; Karrenbeld A; Grond J; Wiggers T; Plukker JT
    Dis Colon Rectum; 2009 Feb; 52(2):260-7. PubMed ID: 19279421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
    Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
    Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
    Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
    Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
    Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
    Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
    Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
    Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
    Berberoglu U
    Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The significance of lymph node involvement in patients with medullary carcinoma of the breast.
    Black CL; Morris DM; Goldman LI; McDonald JC
    Surg Gynecol Obstet; 1983 Dec; 157(6):497-9. PubMed ID: 6648768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma?
    Duraker N; Caynak ZC; Bati B
    Ann Surg Oncol; 2008 Feb; 15(2):430-7. PubMed ID: 17912589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
    Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
    Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
    Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
    Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma.
    Sakata J; Shirai Y; Wakai T; Yokoyama N; Sakata E; Akazawa K; Hatakeyama K
    Eur J Surg Oncol; 2007 Apr; 33(3):346-51. PubMed ID: 17097846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
    Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
    Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.